1. Home
  2. TLRY

as 11-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: NEW YORK
Market Cap: 1.5B IPO Year: 2018
Target Price: $1.88 AVG Volume (30 days): 30.1M
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.27 EPS Growth: N/A
52 Week Low/High: $1.33 - $2.97 Next Earning Date: 01-07-2025
Revenue: $812,037,000 Revenue Growth: 24.76%
Revenue Growth (this year): 18.31% Revenue Growth (next year): 5.26%

TLRY Daily Stock ML Predictions

Share on Social Networks: